Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China
· Delayed Price · Currency is CNY 11.08
+0.01 (0.09%)
May 14, 2025, 2:45 PM CST
SHE:002399 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 5,280 | 5,259 | 5,431 | 7,097 | 6,318 | 5,284 | Upgrade
|
| Other Revenue | - | - | - | 61.92 | 47.33 | 48.04 | Upgrade
|
| Revenue | 5,280 | 5,259 | 5,431 | 7,159 | 6,365 | 5,332 | Upgrade
|
| Revenue Growth (YoY) | -4.31% | -3.17% | -24.14% | 12.48% | 19.38% | 15.30% | Upgrade
|
| Cost of Revenue | 3,633 | 3,520 | 4,490 | 4,861 | 4,367 | 3,300 | Upgrade
|
| Gross Profit | 1,647 | 1,739 | 940.9 | 2,298 | 1,998 | 2,032 | Upgrade
|
| Selling, General & Admin | 1,037 | 1,028 | 1,192 | 975.69 | 850.68 | 821.65 | Upgrade
|
| Research & Development | 4.7 | - | - | 252.14 | 221.1 | 160.01 | Upgrade
|
| Other Operating Expenses | 5.04 | -26.66 | -34.49 | 22.73 | 20.96 | 26.07 | Upgrade
|
| Operating Expenses | 1,044 | 993.5 | 1,158 | 1,299 | 1,165 | 1,018 | Upgrade
|
| Operating Income | 603.05 | 745.82 | -217.29 | 998.55 | 833.53 | 1,014 | Upgrade
|
| Interest Expense | -118.5 | -141.19 | -223.22 | -235.24 | -201.63 | -247.72 | Upgrade
|
| Interest & Investment Income | 124.24 | 104.2 | 75.95 | 54.14 | 54.86 | 301.79 | Upgrade
|
| Earnings From Equity Investments | -141.82 | -141.82 | -447.95 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -12.84 | 85.87 | 186.33 | -205.04 | -248.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 104.92 | -72.08 | -30.71 | -32.55 | -46.18 | -30.47 | Upgrade
|
| EBT Excluding Unusual Items | 571.88 | 482.09 | -757.34 | 971.23 | 435.53 | 788.38 | Upgrade
|
| Impairment of Goodwill | - | - | -68.16 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 237.75 | 315.07 | 16.2 | -176.91 | -226.82 | 494.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.47 | - | - | -2.76 | -5.1 | 0.38 | Upgrade
|
| Asset Writedown | -89.08 | -55.37 | -44.52 | -0.42 | -1.1 | -0.24 | Upgrade
|
| Other Unusual Items | 2.24 | -15.56 | -74.52 | 38.71 | 19.75 | 44.87 | Upgrade
|
| Pretax Income | 723.26 | 726.23 | -928.33 | 829.85 | 222.26 | 1,328 | Upgrade
|
| Income Tax Expense | 96.77 | 101.31 | -126.18 | 114.82 | -11.12 | 306.2 | Upgrade
|
| Earnings From Continuing Operations | 626.49 | 624.92 | -802.16 | 715.04 | 233.38 | 1,022 | Upgrade
|
| Minority Interest in Earnings | 21.8 | 21.82 | 18.9 | 12.39 | 7.4 | 2.58 | Upgrade
|
| Net Income | 648.29 | 646.74 | -783.26 | 727.43 | 240.79 | 1,024 | Upgrade
|
| Net Income to Common | 648.29 | 646.74 | -783.26 | 727.43 | 240.79 | 1,024 | Upgrade
|
| Net Income Growth | - | - | - | 202.10% | -76.49% | -3.32% | Upgrade
|
| Shares Outstanding (Basic) | 1,467 | 1,470 | 1,478 | 1,468 | 1,467 | 1,353 | Upgrade
|
| Shares Outstanding (Diluted) | 1,467 | 1,470 | 1,478 | 1,468 | 1,467 | 1,353 | Upgrade
|
| Shares Change (YoY) | 0.05% | -0.54% | 0.67% | 0.05% | 8.42% | 8.51% | Upgrade
|
| EPS (Basic) | 0.44 | 0.44 | -0.53 | 0.50 | 0.16 | 0.76 | Upgrade
|
| EPS (Diluted) | 0.44 | 0.44 | -0.53 | 0.50 | 0.16 | 0.76 | Upgrade
|
| EPS Growth | - | - | - | 201.95% | -78.32% | -10.90% | Upgrade
|
| Free Cash Flow | - | 1,995 | -39.22 | -979.03 | -200.49 | -175.21 | Upgrade
|
| Free Cash Flow Per Share | - | 1.36 | -0.03 | -0.67 | -0.14 | -0.13 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | - | 0.100 | 0.035 | 0.150 | Upgrade
|
| Dividend Growth | - | - | - | 185.71% | -76.67% | -16.67% | Upgrade
|
| Gross Margin | 31.19% | 33.07% | 17.32% | 32.10% | 31.39% | 38.11% | Upgrade
|
| Operating Margin | 11.42% | 14.18% | -4.00% | 13.95% | 13.10% | 19.01% | Upgrade
|
| Profit Margin | 12.28% | 12.30% | -14.42% | 10.16% | 3.78% | 19.21% | Upgrade
|
| Free Cash Flow Margin | - | 37.93% | -0.72% | -13.68% | -3.15% | -3.29% | Upgrade
|
| EBITDA | - | 1,027 | 105.61 | 1,272 | 1,103 | 1,287 | Upgrade
|
| EBITDA Margin | - | 19.53% | 1.94% | 17.77% | 17.34% | 24.14% | Upgrade
|
| D&A For EBITDA | - | 281.11 | 322.89 | 273.87 | 269.92 | 273.73 | Upgrade
|
| EBIT | 603.05 | 745.82 | -217.29 | 998.55 | 833.53 | 1,014 | Upgrade
|
| EBIT Margin | 11.42% | 14.18% | -4.00% | 13.95% | 13.10% | 19.01% | Upgrade
|
| Effective Tax Rate | 13.38% | 13.95% | - | 13.84% | - | 23.06% | Upgrade
|
| Revenue as Reported | 21 | - | - | 7,159 | 6,365 | 5,332 | Upgrade
|
| Advertising Expenses | - | - | - | 23.2 | 18.04 | 11.66 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.